Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 patient variables associated with the detection of airborne SARS-CoV-2.
Truyols-Vives J, Escarrer-Garau G, Arbona-González L, Toledo-Pons N, Sauleda-Roig J, Ferrer MD, Fraile-Ribot PA, Doménech-Sánchez A, García-Baldoví H, Sala-Llinàs E, Colom-Fernández A, Mercader-Barceló J. Truyols-Vives J, et al. Among authors: fraile ribot pa. J Infect Public Health. 2025 Aug;18(8):102785. doi: 10.1016/j.jiph.2025.102785. Epub 2025 Apr 22. J Infect Public Health. 2025. PMID: 40359823 Free article.
Rapid prediction of carbapenemases in Pseudomonas aeruginosa by imipenem/relebactam and MALDI-TOF MS.
Candela A, Fernández-Billón M, Aja-Macaya P, González-Pinto L, Fraile-Ribot PA, Viedma E, Alonso-García I, Blanco-Martín T, Estévez-Alfaya R, Fernández-González A, Beceiro A, López-Causapé C, Oviaño M, Bou G, Oliver A, Arca-Suárez J. Candela A, et al. Among authors: fraile ribot pa. J Clin Microbiol. 2025 May 14;63(5):e0110524. doi: 10.1128/jcm.01105-24. Epub 2025 Mar 25. J Clin Microbiol. 2025. PMID: 40130831 Free PMC article.
Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms.
Fernández-Billón M, Jordana-Lluch E, Llambías-Cabot AE, Gomis-Font MA, Fraile-Ribot P, Torrandell RI, Colman-Vega PJ, Murillo Ó, Macià MD, Oliver A. Fernández-Billón M, et al. Among authors: fraile ribot p. Biofilm. 2024 Oct 22;8:100231. doi: 10.1016/j.bioflm.2024.100231. eCollection 2024 Dec. Biofilm. 2024. PMID: 39555141 Free PMC article.
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
Herrera C, Gomis-Font MA, López-Causapé C, Díez-Aguilar M, Fraile-Ribot PA, Cardeñoso LM, Oliver A. Herrera C, et al. Among authors: fraile ribot pa. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0116424. doi: 10.1128/aac.01164-24. Epub 2024 Oct 21. Antimicrob Agents Chemother. 2024. PMID: 39431817 Free PMC article.
Impact of transferable β-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake-deficient mutants of Pseudomonas aeruginosa.
González-Pinto L, Blanco-Martín T, Alonso-García I, Rodríguez-Pallares S, Outeda-García M, Gomis-Font MA, Fraile-Ribot PA, Vázquez-Ucha JC, González-Bello C, Beceiro A, Oliver A, Bou G, Arca-Suárez J. González-Pinto L, et al. Among authors: fraile ribot pa. J Antimicrob Chemother. 2024 Nov 4;79(11):3023-3028. doi: 10.1093/jac/dkae326. J Antimicrob Chemother. 2024. PMID: 39287983
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.
González-Pinto L, Alonso-García I, Blanco-Martín T, Camacho-Zamora P, Fraile-Ribot PA, Outeda-García M, Lasarte-Monterrubio C, Guijarro-Sánchez P, Maceiras R, Moya B, Juan C, Vázquez-Ucha JC, Beceiro A, Oliver A, Bou G, Arca-Suárez J. González-Pinto L, et al. Among authors: fraile ribot pa. J Antimicrob Chemother. 2024 Oct 1;79(10):2591-2597. doi: 10.1093/jac/dkae263. J Antimicrob Chemother. 2024. PMID: 39073766 Free PMC article.
Corrigendum to "Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions" [International Journal of Antimicrobial Agents Volume 63, Issue 5 (2024) 107150].
Blanco-Martín T, Alonso-García I, González-Pinto L, Outeda-García M, Guijarro-Sánchez P, López-Hernández I, Pérez-Vázquez M, Aracil B, López-Cerero L, Fraile-Ribot P, Oliver A, Vázquez-Ucha JC, Beceiro A, Bou G, Arca-Suárez J; GEMARA/SEIMC-CIBERINFEC Study Group on the activity and resistance mechanisms to new β-lactams and β-lactamase inhibitors (PROTECT). Blanco-Martín T, et al. Among authors: fraile ribot p. Int J Antimicrob Agents. 2024 Aug;64(2):107264. doi: 10.1016/j.ijantimicag.2024.107264. Epub 2024 Jul 8. Int J Antimicrob Agents. 2024. PMID: 38981815 Free article. No abstract available.
Clinical Characteristics and Microorganisms Isolated in Community-Acquired Pneumonia in the COVID-19 Period.
Gavalda M, Fullana MI, Ferre A, Peña RR, Armendariz J, Torrallardona O, Magraner A, Lorenzo A, García C, Mut G, Planas L, Iglesias C, Fraile-Ribot P, Macia Romero MD, Riera M, García-Gasalla M. Gavalda M, et al. Among authors: fraile ribot p. Can J Infect Dis Med Microbiol. 2024 Mar 19;2024:5948747. doi: 10.1155/2024/5948747. eCollection 2024. Can J Infect Dis Med Microbiol. 2024. PMID: 38532828 Free PMC article.
40 results